使用噻替派、氟达拉滨、抗胸腺细胞球蛋白、低剂量环磷酰胺、200厘戈瑞全身照射及移植后环磷酰胺对镰状细胞病患者进行单倍体相合造血干细胞移植。 - Suppr

Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide.

作者信息

Frangoul Haydar, Evans Misty, Isbell Julie, Bruce Katie, Domm Jennifer

机构信息

Pediatric Stem Cell Transplant Program Children's Hospital at TriStar Centennial and Sarah Cannon Research Institute, Nashville, TN, 37203, USA.

出版信息

Bone Marrow Transplant. 2018 May;53(5):647-650. doi: 10.1038/s41409-017-0077-1. Epub 2018 Jan 16.

DOI:10.1038/s41409-017-0077-1

PMID:29339800

Abstract

摘要

相似文献

Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide.

Bone Marrow Transplant. 2018 May;53(5):647-650. doi: 10.1038/s41409-017-0077-1. Epub 2018 Jan 16.

Haploidentical Stem Cell Transplant With Post Transplant Cyclophosphamide for Chronic Granulomatous Disease With Thiotepa, Busulfan, and Fludarabine as Conditioning.

J Pediatr Hematol Oncol. 2021 May 1;43(4):155-156. doi: 10.1097/MPH.0000000000002015.

A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita.

Bone Marrow Transplant. 2012 Sep;47(9):1254-5. doi: 10.1038/bmt.2011.257. Epub 2012 Jan 16.

Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose.

Am J Hematol. 2018 Nov;93(11):1368-1375. doi: 10.1002/ajh.25257. Epub 2018 Sep 30.

Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.

Biol Blood Marrow Transplant. 2014 Aug;20(8):1176-82. doi: 10.1016/j.bbmt.2014.04.012. Epub 2014 Apr 18.

Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.

Am J Hematol. 2009 Mar;84(3):167-9. doi: 10.1002/ajh.21355.

Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.

Ann Hematol. 2017 Aug;96(8):1373-1377. doi: 10.1007/s00277-017-3030-x. Epub 2017 Jun 1.

Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.

Biol Blood Marrow Transplant. 2010 Nov;16(11):1582-8. doi: 10.1016/j.bbmt.2010.05.010. Epub 2010 May 26.

A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.

Biol Blood Marrow Transplant. 2015 Jan;21(1):119-29. doi: 10.1016/j.bbmt.2014.09.029. Epub 2014 Oct 6.

Using fludarabine to reduce exposure to alkylating agents in children with sickle cell disease receiving busulfan, cyclophosphamide, and antithymocyte globulin transplant conditioning: results of a dose de-escalation trial.

Biol Blood Marrow Transplant. 2015 May;21(5):900-5. doi: 10.1016/j.bbmt.2015.01.015. Epub 2015 Jan 21.

引用本文的文献

Hematopoietic Stem Cell Transplantation in Sickle Cell Disease: A Multidimentional Review.

Cell Transplant. 2024 Jan-Dec;33:9636897241246351. doi: 10.1177/09636897241246351.

Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell disease.

Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):266-271. doi: 10.1182/hematology.2022000371.

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy.

J Clin Med. 2022 Aug 16;11(16):4775. doi: 10.3390/jcm11164775.

Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease.

J Clin Med. 2022 Jun 2;11(11):3160. doi: 10.3390/jcm11113160.

Choice of Donor Source and Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Sickle Cell Disease.

J Clin Med. 2019 Nov 15;8(11):1997. doi: 10.3390/jcm8111997.

Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial.

Lancet Haematol. 2019 Apr;6(4):e183-e193. doi: 10.1016/S2352-3026(19)30031-6. Epub 2019 Mar 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献